- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.09.24 | Novavax's updated Covid-19 vaccine receives FDA emergency use authorisation | ||
| 30.08.24 | Johnson & Johnson seeks FDA approval for generalised myasthenia gravis therapy | ||
| 29.08.24 | Bayer partners with NextRNA to develop lncRNA-targeting cancer therapies | ||
| 28.08.24 | Zuellig Pharma and Regeneron sign deal to supply Libtayo in South Korea and Taiwan | ||
| 27.08.24 | FDA grants orphan drug status for RedHill's opaganib for neuroblastoma | ||
| 26.08.24 | Moderna's RSV vaccine mRESVIA gains EC approval | ||
| 23.08.24 | FDA grants orphan drug status to Ractigen's RAG-18 for DMD and BMD | ||
| 22.08.24 | RedHill launches Talicia in UAE to treat H. pylori infection | ||
| 21.08.24 | GSK's B7-H3-targeted ADC receives FDA breakthrough therapy status | ||
| 20.08.24 | FDA grants Fast Track Designation to Arthrosi Therapeutics's AR882 for gout treatment | ||
| 19.08.24 | EMA validates Type II Variation application for ENHERTU for breast cancer treatment | ||
| 16.08.24 | Aarvik announces ADC option exercise by collaboration partner ArriVent | ||
| 14.08.24 | FDA grants priority review for Bavarian Nordic's chikungunya vaccine BLA | ||
| 13.08.24 | Persist AI and Nivagen to develop AI-driven LAI manufacturing process | ||
| 12.08.24 | Sandoz's Enzeevu secures FDA approval for nAMD treatment | ||
| 09.08.24 | Bavarian Nordic secures $156.8m US vaccine deal | ||
| 08.08.24 | US FDA approves Purdue Pharma's Zurnai auto-injector | ||
| 07.08.24 | FDA accepts Exelixis' cabozantinib sNDA for neuroendocrine tumours | ||
| 06.08.24 | Santen and Cloudbreak enter licence agreement for pterygium treatment | ||
| 05.08.24 | Genmab assumes full ownership of acasunlimab | ||
| 02.08.24 | Health Canada grants approval for Celltrion's Steqeyma for multiple conditions | ||
| 01.08.24 | Jade Biosciences secures $80m to develop autoimmune therapies | ||
| 31.07.24 | Pinetree secures $17m to advance TPD development programmes |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
